- Home
- Companies
- Diaceutics PLC
- Services
- DXRX - Lab Quality Assessment
DXRX - Lab Quality Assessment
What is DXRX Lab Quality Assessment? This program provides pharmaceutical companies with the opportunity to support labs with participation in EQA programs to optimize biomarker testing and expedite commercial therapy and diagnostic launch.
Optimized Commercialization
Pharmaceutical companies implementing a DXRX Lab Quality Assessment at pre-launch stages can access expert advice and support on how to standardize test reports where an EQA program is already in place.
Standardization of Testing Practices
DXRX Lab Quality Assessment enables pharmaceutical companies to standardize testing across labs utilizing the DXRX lab network to reach labs globally and increase test awareness.
Easily interpreted results
Diaceutics establish a Key Opinion Leader (KOL) panel to review test reports to ensure physicians can easily interpret results and identify the most suitable therapy without delay
Report templates and assessments
The DXRX Tech Enable Services team will provide pharma with report templates and assessments as the outcome of the project